Dynamic Changes of Ductus Arteriosus in < 31 Weeks Preterm Infants: an Observational Study
NCT ID: NCT06950164
Last Updated: 2025-04-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
200 participants
OBSERVATIONAL
2025-04-01
2026-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Plasma N-terminal proBNP Concentrations and Patent Ductus Arteriosus in Preterm Babies
NCT00725647
Betamethasone and Closure of Ductus Arteriosus
NCT05987202
Timing of Surgical PDA Ligation and Neonatal Outcomes
NCT04126512
Hemodynamically Important Patent Ductus Arteriosus in Newborns Under 32 Weeks
NCT05686343
Nitric Oxide, Endothelin-1, and the Patency of Ductus Arteriosus in Preterm Infants
NCT00162903
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
observation group
in the group, no intervention was given, and the preterm infants were diagnosed with respiratory distress syndrome(RDS)
observation group
in the group, no intervention was given, and the preterm infants were diagnosed with respiratory distress syndrome(RDS)
control group
in the group, no intervention was given, but the preterm infants were diagnosed without respiratory distress syndrome(RDS)
control group
in the group, no intervention was given, but the preterm infants were diagnosed without respiratory distress syndrome(RDS)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
observation group
in the group, no intervention was given, and the preterm infants were diagnosed with respiratory distress syndrome(RDS)
control group
in the group, no intervention was given, but the preterm infants were diagnosed without respiratory distress syndrome(RDS)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* admission with 1 hours after birth
Exclusion Criteria
* parents' refusal
1 Minute
1 Hour
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chongqing Medical Center for Women and Children
OTHER
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Chen Long,MD
director
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Women and Children's hospital of Chonqing Medical University
Chongqing, Chongqing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ductus arteriosus
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.